These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1126 related articles for article (PubMed ID: 34108465)

  • 41. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
    Le Bert N; Clapham HE; Tan AT; Chia WN; Tham CYL; Lim JM; Kunasegaran K; Tan LWL; Dutertre CA; Shankar N; Lim JME; Sun LJ; Zahari M; Tun ZM; Kumar V; Lim BL; Lim SH; Chia A; Tan YJ; Tambyah PA; Kalimuddin S; Lye D; Low JGH; Wang LF; Wan WY; Hsu LY; Bertoletti A; Tam CC
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33646265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful Treatment of Persistent SARS-CoV-2 Infection in a B-Cell Depleted Patient with Activated Cytotoxic T and NK Cells: A Case Report.
    Jassem J; Marek-Trzonkowska NM; Smiatacz T; Arcimowicz Ł; Papak I; Jassem E; Zaucha JM
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
    PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.
    Zheng M; Karki R; Williams EP; Yang D; Fitzpatrick E; Vogel P; Jonsson CB; Kanneganti TD
    Nat Immunol; 2021 Jul; 22(7):829-838. PubMed ID: 33963333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.
    Wang X; Huang K; Jiang H; Hua L; Yu W; Ding D; Wang K; Li X; Zou Z; Jin M; Xu S
    Virol Sin; 2020 Dec; 35(6):793-802. PubMed ID: 33156486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemical Exposures Affect Innate Immune Response to SARS-CoV-2.
    Arowolo O; Pobezinsky L; Suvorov A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
    Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
    mBio; 2021 May; 12(3):. PubMed ID: 33947753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD4
    Popescu I; Snyder ME; Iasella CJ; Hannan SJ; Koshy R; Burke R; Das A; Brown MJ; Lyons EJ; Lieber SC; Chen X; Sembrat JC; Bhatt P; Deng E; An X; Linstrum K; Kitsios G; Konstantinidis I; Saul M; Kass DJ; Alder JK; Chen BB; Lendermon EA; Kilaru S; Johnson B; Pilewski JM; Kiss JE; Wells AH; Morris A; McVerry BJ; McMahon DK; Triulzi DJ; Chen K; Sanchez PG; McDyer JF
    Am J Respir Crit Care Med; 2022 Jun; 205(12):1403-1418. PubMed ID: 35348444
    [No Abstract]   [Full Text] [Related]  

  • 49. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
    Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
    J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Profiles of Peripheral Immune Cells of Uncomplicated COVID-19 Cases with Distinct Viral RNA Shedding Periods.
    Putri DU; Wang CH; Tseng PC; Lee WS; Chen FL; Kuo HP; Lee CH; Lin CF
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33808906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low numbers and altered phenotype of invariant natural killer T cells in recurrent varicella zoster virus infection.
    Novakova L; Lehuen A; Novak J
    Cell Immunol; 2011; 269(2):78-81. PubMed ID: 21570064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.
    Hoste L; Roels L; Naesens L; Bosteels V; Vanhee S; Dupont S; Bosteels C; Browaeys R; Vandamme N; Verstaen K; Roels J; Van Damme KFA; Maes B; De Leeuw E; Declercq J; Aegerter H; Seys L; Smole U; De Prijck S; Vanheerswynghels M; Claes K; Debacker V; Van Isterdael G; Backers L; Claes KBM; Bastard P; Jouanguy E; Zhang SY; Mets G; Dehoorne J; Vandekerckhove K; Schelstraete P; Willems J; ; Stordeur P; Janssens S; Beyaert R; Saeys Y; Casanova JL; Lambrecht BN; Haerynck F; Tavernier SJ
    J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34914824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unique immunological profile in patients with COVID-19.
    Varchetta S; Mele D; Oliviero B; Mantovani S; Ludovisi S; Cerino A; Bruno R; Castelli A; Mosconi M; Vecchia M; Roda S; Sachs M; Klersy C; Mondelli MU
    Cell Mol Immunol; 2021 Mar; 18(3):604-612. PubMed ID: 33060840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
    Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
    J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.
    Tomić S; Đokić J; Stevanović D; Ilić N; Gruden-Movsesijan A; Dinić M; Radojević D; Bekić M; Mitrović N; Tomašević R; Mikić D; Stojanović D; Čolić M
    Front Immunol; 2021; 12():614599. PubMed ID: 33692788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73
    Ahmadi P; Hartjen P; Kohsar M; Kummer S; Schmiedel S; Bockmann JH; Fathi A; Huber S; Haag F; Schulze Zur Wiesch J
    Cells; 2020 Jul; 9(8):. PubMed ID: 32707842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients.
    Wang X; Bai H; Ma J; Qin H; Zeng Q; Hu F; Jiang T; Mao W; Zhao Y; Chen X; Qi X; Li M; Xu J; Hao J; Wang Y; Ding X; Liu Y; Huang T; Fang C; Ge C; Li D; Hu K; Ren X; Zhang B; Zhang B; Shi B; Zhang C
    Front Immunol; 2022; 13():812514. PubMed ID: 35281000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors for prolonged virus shedding of respiratory tract and fecal in adults with severe acute respiratory syndrome coronavirus-2 infection.
    Zhang S; Zhu H; Ye H; Hu Y; Zheng N; Huang Z; Xiong Z; Fu L; Cai T
    J Clin Lab Anal; 2021 Sep; 35(9):e23923. PubMed ID: 34390043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity.
    Kim H; Byun JE; Yoon SR; Koohy H; Jung H; Choi I
    Cell Immunol; 2022 Jan; 371():104454. PubMed ID: 34773897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.